Hempfusion Wellness Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Maria Leal
- Full Time Employees
- 47
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 1055 West Georgia Street Vancouver BC Canada V6E 4N7
- IPO Date
- Feb 2, 2021
- Website
- hempfusion.com
- Similar Companies
- Business
- Hempfusion Wellness Inc. is a health and wellness company specializing in the development, manufacturing, marketing, and distribution of hemp-derived cannabidiol (CBD) products and probiotic supplements. The company offers an extensive portfolio that includes tinctures, capsules, gummies, topicals such as pain relief creams, wound healing ointments, and skin care products under its flagship HempFusion brand, as well as the Sagely Naturals and Apothecanna brands. Its products are manufactured under current Good Manufacturing Practice (cGMP) standards and cover broad-spectrum CBD and whole-food hemp extracts combined with other natural ingredients. Hempfusion Wellness markets over 100 SKUs in approximately 18,000 retail stores across the United States and internationally, with e-commerce platforms serving as additional distribution channels. The company targets health-conscious consumers seeking premium CBD and probiotic wellness products. Founded in 2019 and headquartered in Denver, Colorado, Hempfusion Wellness has recently undertaken significant business changes including expanding its retail distribution network into top U.S. supermarket chains to increase store presence by thousands of locations. The company has achieved self-affirmed Generally Recognized As Safe (GRAS) status for its proprietary hemp-derived CBD extract, facilitating its use in foods, beverages, and dietary supplements, positioning it for expanded retail acceptance amid evolving FDA regulatory landscapes. Hempfusion has also focused on launching new ingestible and topical CBD products, broadening its product innovation pipeline. Despite operational challenges in past years, including financial filings delays, Hempfusion Wellness maintains a strategic emphasis on cost-saving initiatives, ongoing product development, and expanding global footprint with targeted growth in Europe, Asia, and Latin America. These strategic moves support its goal to enhance market share and revenue, with a clean balance sheet and efforts to scale e-commerce and retail distribution channels effectively.
Hempfusion Wellness completes sale of assets and operations of probiotic business to Kadenwood
HempFusion Wellness reports a rise in Q4 and fiscal 2021 revenue amid declining costs
HempFusion Wellness announces brokered private placement to raise up to US$3.0M in aggregate gross proceeds
HempFusion Wellness says its hemp-derived CBD extract achieves “major regulatory milestone”
HempFusion Wellness unveils $4M annual savings initiative and updates on retail growth
Hempfusion Wellness Inc. (CBDHF) CEO Dr. Jason Mitchell on Q3 2021 Results - Earnings Call Transcript
HempFusion Wellness reports year-over-year, triple-digit increase in 3Q revenue
HempFusion's Q3 Revenue Spikes 155% YoY, Accelerates Sales Activity in Q4
HempFusion drives growth with its popular hemp-based CBD and probiotic products
HempFusion launches ingestible and topical CBD products into another Top 15 US supermarket chain
HempFusion Wellness to launch CBD products in Arizona retail market through key grocery channel
HempFusion's Stock Slightly Up On Announcing Sagely Naturals' Launch Into Top 10 US Retail Outlets
HempFusion subsidiary Sagely Naturals launches into Top 10 US retailer
HempFusion Wellness promotes Maria Leal to the post of chief financial officer
HempFusion Wellness closes previously announced private placement for gross proceeds of approximately US$2.94 million
HempFusion Wellness closes previously announced private placement for gross proceeds of approximately US$2.94 million
HempFusion Wellness increases its private placement to over US$2.5M due to greater investor demand
HempFusion Wellness reveals US$2M strategic private placement
HempFusion Wellness expansion plans expected to boost its FY2021 revenue to between US$12.5M and US$13.5M
HempFusion Wellness expansion plans expected to boost its FY2021 revenue to US$12.5M to US$13.5M